| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/05/2008 | CN101134101A 5T4 tumour-associated antigen |
| 03/05/2008 | CN100373375C System and method for controlling user interface attribute by data |
| 03/05/2008 | CN100372938C Gene encoding labyrinthin, a marker for cancer |
| 03/05/2008 | CN100372935C Cloning of gene against meloidogyne of capsicum and application thereof |
| 03/05/2008 | CN100372934C Homologous sequence linked with yellow dwarf-resistant gene Bdv2 and use thereof |
| 03/05/2008 | CN100372932C Positive regulation gene for cell cycle and its coded protein and uses |
| 03/05/2008 | CN100372871C Promoter to IL-18BP, its preparation and use |
| 03/05/2008 | CN100372870C Polyethylene glycol derivatives of thymosin alphal |
| 03/05/2008 | CN100372869C Antimicrobial polypeptide from Amolops loloensis and its pharmaceutical use |
| 03/05/2008 | CN100372868C Transcription factor for regulating plant fallen, its coding gene and use |
| 03/05/2008 | CN100372572C Recombinant plasmid with human thymosin Beta-4gene |
| 03/05/2008 | CA2600168A1 Markers of renal transplant rejection and renal damage |
| 03/04/2008 | US7339097 Inbred corn line PHD90 |
| 03/04/2008 | US7339093 Soybean cultivar S06-WW013107 |
| 03/04/2008 | US7339092 Plant activation of Cry8Bb1 by insertion of a plant protease-sensitive site |
| 03/04/2008 | US7339089 Transgenic cell comprising human leukocyte antigen binding peptide for use as tools diagnosis, prevention and treatment of cell proliferative disorders; genetic vaccines |
| 03/04/2008 | US7339048 Genes encoding genetic stability, gene expression and folding proteins |
| 03/04/2008 | US7339047 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases |
| 03/04/2008 | US7339046 CFTR with a partially deleted R domain and uses thereof |
| 03/04/2008 | US7339044 Nematode PAN and ZP receptor-like sequences |
| 03/04/2008 | US7339043 Compositions and methods for affecting virulence determinants in bacteria |
| 03/04/2008 | US7339042 cytotoxic fusion proteins that are useful for selectively killing endothelial cells in blood vessels that feed tumors |
| 03/04/2008 | US7339040 DNA molecules optimized sequences that encode the IA-2IC antigen, RNA molecules, expression vectors, transformed cells, method of preparing the IA-2IC antigen, polypeptide of the human IA-2IC antigen, and in vitro procedure and kit for the diagnosis of autoimmune diabetes |
| 03/04/2008 | US7339039 Nucleic acids encoding receptor recognition factors, and methods of use thereof |
| 03/04/2008 | US7339038 Heparanase specific molecular probes and their use in research and medical applications |
| 03/04/2008 | US7339037 nucleoside sequence polypeptides; therapy, prevention of influenza viral infections |
| 03/04/2008 | US7339032 Polypeptides, fragments and homologues; vectors, host cells, antibodies; genetic engineering and expression; treatment of urogenital, sexual, metabolic, inflammatory, pregnancy, and g-protein coupled receptor disorders; drug screening |
| 03/04/2008 | US7339031 Cancer therapeutics; inhibits protein synthesis on ribosomes |
| 03/04/2008 | US7339030 Human semaphorin L (H-SemaL) and corresponding semaphorins in other species |
| 03/04/2008 | US7339029 Sperm-specific cation channel, CatSper2, and uses therefor |
| 03/04/2008 | US7339028 Mahoganoid polypeptides, and related compositions and methods |
| 03/04/2008 | US7339027 Human prolactin antagonist-angiogenesis inhibitor fusion proteins |
| 03/04/2008 | US7339025 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferation disorders |
| 03/04/2008 | US7339024 PRO1772 polypeptides |
| 03/04/2008 | US7339023 Angiogenesis inhibitors, antitumor agents |
| 03/04/2008 | US7339022 Histological certification of lymphatic vessels and the immunohistochemical inspection for malignant invasion into the lymphatic vessels; an epitope of a lymphatic vessel-specific antibody; immunostaining |
| 03/04/2008 | US7338937 Calcium-activated chloride channel proteins and their use in anti-metastatic therapy |
| 03/04/2008 | US7338936 Administering a defensin (EP2E) to treat infections caused by Hemophilus influenzae strain 12, Moraxella catarrhalis, or Streptococcus pneumoniae serotype 3 or serotype; labyrinthitis and meningitis |
| 03/04/2008 | US7338935 Isolating interferon polypeptides using size exclusion chromatography; antitumor agents; viricides; immunomodulators |
| 03/04/2008 | US7338934 Fibroblast growth factor-14 |
| 03/04/2008 | US7338933 Human Growth Hormone polypeptide comprising an O-linked glycosylation site that does not exist in a wild type polypeptide; glycoconjugates in which a species such as a water-soluble polymer, a therapeutic agent or a biomolecule is covalently linked through the site |
| 03/04/2008 | US7338929 Cancer immunotherapy |
| 03/04/2008 | US7338807 Using expression vector coding tumor supressor protein to identify compounds which induce cell death; diagnosing xeroderma pigmentosum |
| 03/04/2008 | US7338799 Polynucleotide encoding a mouse choline transporter |
| 03/04/2008 | US7338797 Compositions for isolating a cDNA encoding a membrane-bound protein |
| 03/04/2008 | US7338794 Amended recombinant cells for the production and delivery of gamma interferon as an antiviral agent, adjuvant and vaccine accelerant |
| 03/04/2008 | US7338793 Methods and compositions for cyclizing diterpenes |
| 03/04/2008 | US7338787 Lowering circulating free fatty acid levels in an individual by administering purified, isolated, or recombinant OBG3 or gOBG3 polypeptide fragment that has significantly greater activity than a full-length OBG3 polypeptide; treatment of hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 03/04/2008 | US7338786 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 03/04/2008 | US7338781 Organic anion transporting (oat)-like protein UST3-LIKE1 and uses thereof |
| 03/04/2008 | US7338779 Genetically modifying the Trichoderma production host in such a way that the microorganism does not produce an essential amount of at least one of the proteins, polypeptides or peptides associated with foam formation during cultivation of the unmodified microorganism |
| 03/04/2008 | US7338772 RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate |
| 03/04/2008 | US7338770 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis |
| 03/04/2008 | US7338769 Methods for identifying agonists of cypin |
| 03/04/2008 | US7338766 Activating adenine triphosphate independent cytolytic modulator for use in the treatment of infection and cancer; generate nutrient broth, propagate microorganisms, allow microorganism to secrete protein, recover protein; inhibiting parasitemia of Plasmodium falciparum |
| 03/04/2008 | US7338662 Recombinant poxvirus expressing homologous genes inserted into the foxviral genome |
| 03/04/2008 | US7338661 Infectious bursal disease virus antigenic isolates and vaccines |
| 03/04/2008 | US7338656 Composition and method to alter lean body mass and bone properties in a subject |
| 03/04/2008 | US7338653 Amino-terminally truncated MCP-2 as chemokine antagonists |
| 03/01/2008 | CA2598060A1 Methods and compositions for the treatment and prevention of cancer |
| 03/01/2008 | CA2597840A1 Methods and compositions for the treatment and prevention of cancer |
| 02/28/2008 | WO2008025032A1 Soluble il-27 receptor |
| 02/28/2008 | WO2008024840A2 Aqueous processing of oilseed press cake |
| 02/28/2008 | WO2008024300A1 SEMAPHORIN 7A PLAYS A CRITICAL ROLE IN TGF-β1-INDUCED PULMONARY FIBROSIS AND ALVEOLAR DESTRUCTION |
| 02/28/2008 | WO2008023717A1 Ophthalmic agent comprising pacap peptide |
| 02/28/2008 | WO2008023469A1 Method of identifying transcriptional factor inducing the production of monascus-origin physiologically active substance and utilization thereof |
| 02/28/2008 | WO2008023060A1 Fermentation process |
| 02/28/2008 | WO2008023050A1 Acylated exendin-4 compounds |
| 02/28/2008 | WO2008022963A2 Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains |
| 02/28/2008 | WO2008022774A2 Biosilica-adhesive protein nanocomposite materials: synthesis and application in dentistry |
| 02/28/2008 | WO2008022772A1 Use of light sensitive genes |
| 02/28/2008 | WO2008022759A2 Specific and high affinity binding proteins comprising modified sh3 domains of fyn kinase |
| 02/28/2008 | WO2008022716A2 Screening method for gpcr ligands |
| 02/28/2008 | WO2008022645A2 Ncam fibronectin type 3 binding peptides |
| 02/28/2008 | WO2008022486A1 Plant growth and stress tolerance related isozyme, encoding gene and use thereof |
| 02/28/2008 | WO2008022444A1 Small cationic antimicrobial peptides |
| 02/28/2008 | WO2008022401A1 Recombinant hcv e2 glycoprotein |
| 02/28/2008 | WO2008003925A3 Complement protein |
| 02/28/2008 | WO2008003612A3 Analogs of vasoactive intestinal peptide |
| 02/28/2008 | WO2007137973A9 Manipulation of the nitrogen metabolism using ammonium transporter or glucose 6-phosphate deshydrogenases or farnesyl phosphate synthetase (fpp) |
| 02/28/2008 | WO2007137586A3 Random insertion of peptides |
| 02/28/2008 | WO2007124284A3 Bombesin receptor anatogonists with anti-cancer activity |
| 02/28/2008 | WO2007113837A3 N-terminal vdac variants and uses thereof |
| 02/28/2008 | WO2007103956A3 Compositions and methods for increasing plant tolerance to high population density |
| 02/28/2008 | WO2007093848A3 Crystalline enoyl-(acyl-carrier-protein) reductase from heliobacter pylori |
| 02/28/2008 | WO2007069090A3 Cell penetrating peptides for intracellular delivery of molecules |
| 02/28/2008 | WO2007051477A8 Neurotrophin-derived peptide sequences |
| 02/28/2008 | WO2004033637A8 Extracellular messengers |
| 02/28/2008 | WO2003059954A8 Method for specifically immobilizing mediator molecules on substrate surfaces |
| 02/28/2008 | WO2001070932A3 Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife |
| 02/28/2008 | US20080052794 Casein Kinase Stress-Related Polypeptides And Methods Of Use In Plants |
| 02/28/2008 | US20080052793 Seeds |
| 02/28/2008 | US20080052792 Transgenic plant cell comprising expression vector coding regulatory protein for use in enhancement of drought resistant plants |
| 02/28/2008 | US20080052787 Chimeric gene constructs for generation of fluorescent transgenic ornamental fish |
| 02/28/2008 | US20080051565 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 02/28/2008 | US20080051561 Residual solvent extraction method and microparticles produced thereby |
| 02/28/2008 | US20080051557 Stable Analogs of Peptide and Polypeptide Therapeutics |
| 02/28/2008 | US20080051556 Novel PTP-20, PCP-2, BDP1, CLK, and SIRP proteins and related products and methods |
| 02/28/2008 | US20080051555 Support Having Affinity for Antibody |
| 02/28/2008 | US20080051376 Method for Producing Albumin-Corticoid Conjugates |